73
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Effect of three months’ treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31 793 patients

, &
Pages 1433-1440 | Accepted 19 Jul 2005, Published online: 22 Aug 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Peter Bramlage. (2009) Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension. Vascular Health and Risk Management 5, pages 213-224.
Read now
Peter Bramlage, Isabelle Durand-Zaleski, Nisha Desai, Olaf Pirk & Caroline Hacker. (2009) The value of irbesartan in the management of hypertension. Expert Opinion on Pharmacotherapy 10:11, pages 1817-1831.
Read now

Articles from other publishers (6)

Nathalia Buitrago-Gómez, Natalia Campo-Rivera, Lunevar Figueroa-Torregroza & María Eugenia Casanova-Valderrama. (2022) Hipertensión arterial esencial: ¿cuál agente antihipertensivo elegir?. Salud UIS 54:1.
Crossref
S R Gilyarevsky. (2014) The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience. Systemic Hypertension 11:2, pages 67-71.
Crossref
Robert Petrella & Paul Michailidis. (2011) Retrospective Analysis of Real-World Efficacy of Angiotensin Receptor Blockers Versus Other Classes of Antihypertensive Agents in Blood Pressure Management. Clinical Therapeutics 33:9, pages 1190-1203.
Crossref
Katherine F Croom & Greg L Plosker. (2008) Irbesartan. Drugs 68:11, pages 1543-1569.
Crossref
Elijah Saunders, Greg Cable & Joel Neutel. (2008) Predictors of Blood Pressure Response to Angiotensin Receptor Blocker/Diuretic Combination Therapy: A Secondary Analysis of the Irbesartan/Hydrochlorothiazide Blood Pressure Reductions in Diverse Patient Populations (INCLUSIVE) Study. The Journal of Clinical Hypertension 10:1, pages 27-33.
Crossref
G. I. Varughese & J. H. B. Scarpello. (2006) Response to: Angiotensin receptor blockers in hypertension: the emerging role in diabetes mellitus. International Journal of Clinical Practice 60:8, pages 1010-1012.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.